Ray Shuvanan, Mazumder Alok, Kumar Soumitra, Bhattacharjee Prithwiraj, Rozario David, Bandyopadhyay Siddhartha, Mukherjee Sanjeev S, Deb P K, Bandyopadhyay Amal
Chief of Cardiac Intervention, Fortis Hospital, Anandapur, Kolkata, India.
Head of the Department of Cardiology, B.R. Singh Hospital, Kolkata, India.
Indian Heart J. 2016 Jan-Feb;68(1):28-35. doi: 10.1016/j.ihj.2015.07.014. Epub 2016 Jan 18.
Coronary artery bypass graft surgery is the standard treatment of unprotected left main coronary stenosis (ULMCA). However, in the real world scenario, many of these patients are unfit for CABG or prefer angioplasty as an alternative when offered the choice.
A total of 86 clinically stable patients with ULMCA stenosis who were unfit or unwilling for CABG underwent PCI with DES at two tertiary care centers in Kolkata. Patients were followed up prospectively for a median of 34.6 months for major adverse cardiovascular events. Angiographic follow-up was done after 1 year of index procedure or earlier, if indicated.
Fifty-five patients (64%) had distal left main stenosis. Two-stent technique was used in 19 patients (22%) and single-stent technique in 36 patients (42%) with distal left main lesion. Thirteen patients (15.1%) had left ventricular ejection fraction (LVEF) of ≤45%. There was no in-hospital death, MI, or stent thrombosis. During follow-up, major adverse cardiac event (MACE) occurred in 9 patients (10.5%). Our study revealed significantly greater MACE in patients with distal left main lesion with LVEF ≤45% (50% vs 6.38%, p=0.0002), high SYNTAX score (36.36% vs 6.82%, p=0.008), and diabetes (17.95% vs 0.00%, p=0.07). Overall, also patients with Diabetes, LVEF ≤ 45%, and SYNTAX score >32 had significantly higher MACE. Use of IC Stent, IVUS, or procedural strategy in distal lesion did not affect MACE.
In selective patients with low-intermediate SYNTAX score and without diabetes and LV dysfunction, ULMCA PCI with DES is feasible.
冠状动脉旁路移植术是无保护左主干冠状动脉狭窄(ULMCA)的标准治疗方法。然而,在现实世界中,这些患者中的许多人不适合进行冠状动脉旁路移植术(CABG),或者在有选择的情况下更倾向于选择血管成形术作为替代方案。
在加尔各答的两个三级医疗中心,对86例临床稳定的ULMCA狭窄患者进行了药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI),这些患者不适合或不愿意接受CABG。对患者进行前瞻性随访,中位随访时间为34.6个月,观察主要不良心血管事件。在首次手术1年后或如有指征则更早进行血管造影随访。
55例患者(64%)存在左主干远端狭窄。19例(22%)左主干远端病变患者采用双支架技术,36例(占42%)采用单支架技术。13例患者(15.1%)左心室射血分数(LVEF)≤45%。住院期间无死亡、心肌梗死或支架血栓形成。随访期间,9例患者(10.5%)发生主要不良心脏事件(MACE)。我们的研究显示,左主干远端病变且LVEF≤45%的患者MACE发生率显著更高(50%对6.38%,p = 0.0002)、SYNTAX评分高的患者(36.36%对6.82%,p = 0.008)以及糖尿病患者(17.95%对0.00%,p = 0.07)。总体而言,糖尿病、LVEF≤45%且SYNTAX评分>32的患者MACE也显著更高。在远端病变中使用IC支架、血管内超声(IVUS)或手术策略并不影响MACE。
对于中低SYNTAX评分、无糖尿病且无左心室功能障碍的选择性患者,采用DES进行ULMCA PCI是可行的。